Patients with follicular lymphoma (FL) who progress within 24 months of front-line therapy (POD24) have poor outcomes, but clinical factors predicting earl
The U.S. has confirmed its first known severe human infection of H5N1 bird flu, in a person in Louisiana.
This cohort study compares survival of high-risk patients with screen-detected pancreatic cancer with a matched cohort from the Surveillance, Epidemiology, and End Results program.
A prospective repository of longitudinal, real-world patient-reported outcomes (PRO) and quality of life data for patients with blood disorders.
Dyslipidaemia in patients with diabetes contributes to the risk of atherosclerotic cardiovascular disease. We aimed to identify a dyslipidemic profile associated with both dysglycemia and…
On December 18, 2024, the Food and Drug Administration approved ensartinib (Ensacove, Xcovery Holdings, Inc.) for adult patients with anaplastic lymphoma kinase (ALK)-positive locally advanced…
The U.S. has confirmed its first known severe human infection of H5N1 bird flu, in a person in Louisiana.
On December 18, 2024, the Food and Drug Administration approved ensartinib (Ensacove, Xcovery Holdings, Inc.) for adult patients with anaplastic lymphoma kinase (ALK)-positive locally advanced…
Nature – Whole-genome sequencing of matched serial tumours from patients identifies two key mutagenic factors (APOBEC3 and chemotherapy) and extrachromosomal DNA-forming structural variants that…
Traditional and new cancer therapies often become stymied due to tumor resistance, but why resistance arises and how to avoid it remain important questions in…
